PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests
Company Expands Diagnostic Services with K9 Clone DOG-1 Immunohistochemical and H. pylori Monoclonal Antibody Tests
PLUS Diagnostics also announced that it is the first U.S. laboratory to beta test an H. pylori monoclonal antibody test that detects H. pylori infection. Afflicting as many as 30 percent of Americans, H. pylori can be difficult to distinguish from other bacteria in routine staining assays. The infection, which is commonly caused by ingesting contaminated water or food, can cause peptic ulcer disease and gastric malignancy when left untreated. PLUS Diagnostics’ new test is expected to reduce the number of false positive H. pylori cases.
“These tests are at the forefront of science and innovation, and support our goal of providing our customers with leading diagnostic services that enable them to offer their patients the highest quality of care,” said
PLUS Diagnostics has expanded its services since the company partnered with Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care. It recently opened a West Coast laboratory and announced plans to expand into diagnostics services for hematology/oncology, in addition to the gastroenterology and urology specialties it serves today.
About PLUS Diagnostics
PLUS Diagnostics is a leading national anatomic pathology company that provides a full range of multi-specialty services, including extensive diagnostic procedures and specialist consultations. Accredited by the College of American Pathologists, PLUS Diagnostics has long been recognized for exceptional service and quality. The company currently focuses on a broad base of specialty pathology services, including urology and gastroenterology with plans to expand into hematopathology this year. For more information, visit, www.plusdx.com.
SOURCE PLUS Diagnostics